Business news

    ASX lower; Pro Medicus hit a fresh record on FY results; IDT surged 27% on vaccine report

    Article Image
    Highlights
    • ASX200 closed 0.12% lower at 7502.10 on Wednesday.
    • Pro Medicus jumped 15% to a record high share price on FY21 results.
    • IDT Australia soared on reports of a deal with the federal government.

    The Australian market overturned morning gains to close lower for a third straight session on Wednesday as the resources and metals and mining sectors plummeted more than 3% each.

    The tech sector closed in positive territory today, boosted by strong gains for Wisetech Global, Codan, Appen and Xero.

    Bitcoin is trading 1.28% lower over the last 24-hours at US$45,308.75 at 4:30pm AEST.

    Medical imaging software company Pro Medicus soared more than 15% to a record high share price $65.35/share following the release of FY21 results. For the 12-month period Pro Medicus reported a record number of new contracts, revenue from customers increased 19.5% to $67.9m, and underlying profit before tax was $42.6m, up 41% from the previous corresponding period.

    Making headlines, IDT Australia skyrocketed 27% today after the Sydney Morning Herald reported the pharmaceutical company is seeking to work with the federal government to produce mRNA vaccines in Australia. IDT said it will use existing manufacturing capabilities near Melbourne?s Monash University to create the vaccine.

    And competition in the buy now, pay later sector intensified today as the Commonwealth Bank officially launched its ?StepPay? offering to its 4 million-strong customer base.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa